Why I’m avoiding the temptation to buy Xaar plc and Integrated Diagnostic Holdings plc

Here’s why I’m keeping away from Xaar plc (LON:XAR) and Integrated Diagnostic Holdings plc (LON:IDHC) despite them looking attractive on the surface.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

sdf

Inkjet technology expert Xaar (LSE: XAR) delivered full-year results that disappointed the market today with the shares down around 8% as I write.

Profits slipping

Although adjusted revenue was up 2.9% compared to a year ago, profit before tax slipped by 6.3% and diluted earnings per share dropped 13%. Net cash inflow from operations plunged 65%, the gross profit margin slipped 3% and the operating margin jolted down 9%.

That looks like a lot of negatives in the figures so I’m not surprised to see the shares down today, which continues a plunge from over 550p during the autumn of 2015 – a decline in excess of 39% at today’s 333p price.

Chief executive Doug Edwards explained that the firm is aiming to convert customers from well-established analogue manufacturing techniques to digital inkjet solutions and drive up revenues to £220m by 2020. Today’s revenue figure of just over £96m suggests the size of the opportunity for Xaar, but the big question is will those revenues, if they occur, generate meaningful profits for the firm? Based on today’s reporting, I don’t think we can take it for granted that they will.

Ploughing capital into R&D

Part of the challenge could be that Xaar seems to invest a lot of capital in research and development (R&D), much of it just to stay ahead of the game in the face of fierce competition. Gross R&D spend was up 12.5% at £22.4m, which is around 1.3 times operating profits. The stakes are high, and if today’s R&D doesn’t hit the mark by generating profitable products, the shares could slip further down.

On the other hand, investment in R&D can really drive good trading when it clicks, but I’d want to see evidence of improvements in the figures and a share price turning up before investing.

Stellar trading

It’s hard to fault Egyptian medical diagnostics firm Integrated Diagnostics Holdings’ (LSE: IDHC) trading figures presented in today’s full-year report. Revenues and gross profit inflated 15% compared to a year ago, net profit rocketed 72% and earnings per share shot up a massive 79%.

On that showing, it seems safe to conclude that trading went well. The directors agree, hiking the dividend by 100%. However, the firm’s location in Egypt caused problems due to a 50% deflation of the Egyptian pound, which led to a net foreign exchange loss of EGP89m.

 Chief Executive Dr Hend El-Sherbini reckons the firm worked hard to reduce costs and increase sales to mitigate the negative effects of currency valuation and inflation. She said: “Our ability to keep the costs of our materials in check reflects both the strength of our supplier relationships and the significant volumes we regularly purchase from them.”

Despite the strength of the firm’s financial results, I feel uneasy about Integrated Diagnostic’s exposure to such volatile currency movements due to its location in the world. The shares seem locked in a wilful downtrend too, falling some 135% since August 2015. Taken together, these reasons are enough to keep me away from the shares.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Kevin Godbold has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Finger clicking a button marked 'Buy' on a keyboard
Investing Articles

Analysts have upgraded this FTSE 100 stock to Buy. What should investors do?

Associated British Foods shares have been uninspiring for some time. But is it finally time to consider buying the FTSE…

Read more »

Man changing battery on electric bicycle
Investing Articles

Prediction: in 12 months the sizzling National Grid share price could turn £10,000 into…

It's been another solid year for the National Grid share price and the dividend yield is decent too. So why…

Read more »

Businessman using pen drawing line for increasing arrow from 2024 to 2025
Investing Articles

Up 185% in 3 years, why does the market love this FTSE 250 stock

Over the past three years, this stock has vastly outperformed the FTSE 250. Dr James Fox takes a closer look…

Read more »

A handsome mature bald bearded black man in a sunglasses and a fashionable blue or teal costume with a tie is standing in front of a wall made of striped wooden timbers and fastening a suit button
Investing Articles

Looking for growth, dividends, or value? These 3 ETFs could be smart ideas to consider

Exchange-traded funds (ETFs) provide a way for investors to spread risk without sacrificing the possibility of huge long-term returns.

Read more »

Happy couple showing relief at news
Investing Articles

Is the Rolls-Royce share price fast becoming a joke?

The FTSE 100 engineering titan has done brilliantly in recent years. But our writer wonders whether the Rolls-Royce share price…

Read more »

Middle-aged white male courier delivering boxes to young black lady
Investing Articles

Is there a ‘best age’ to start buying shares?

Christopher Ruane weighs some possible pros and cons of waiting to start buying shares for the first time, versus starting…

Read more »

piggy bank, searching with binoculars
Investing Articles

Is it time to look again at the FTSE 250’s worst performers?

Our writer considers the prospects for two of the worst-performing shares on the FTSE 250, with falls of at least…

Read more »

A handsome mature bald bearded black man in a sunglasses and a fashionable blue or teal costume with a tie is standing in front of a wall made of striped wooden timbers and fastening a suit button
Investing For Beginners

Down over 40% in the past year, I think investors should consider these value shares

Jon Smith points out two value shares that have fallen heavily over the past year but are starting to look…

Read more »